|
1
|
Hung CC, Lin HY, Hwang DY, Kuo IC, Chiu
YW, Lim LM, Hwang SJ and Chen HC: Diabetic retinopathy and clinical
parameters favoring the presence of diabetic nephropathy could
predict renal outcome in patients with diabetic kidney disease. Sci
Rep. 7:12362017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Das F, Ghosh-Choudhury N, Venkatesan B,
Kasinath BS and Choudhury Ghosh G: PDGF receptor-β uses Akt/mTORC1
signaling node to promote high glucose-induced renal proximal
tubular cell collagen I (α2) expression. Am J Physiol Renal
Physiol. 313:F291–F307. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen YL, Qiao YC, Xu Y, Ling W, Pan YH,
Huang YC, Geng LJ, Zhao HL and Zhang XX: Serum TNF-α concentrations
in type 2 diabetes mellitus patients and diabetic nephropathy
patients: A systematic review and meta-analysis. Immunol Lett.
186:52–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eissa S, Matboli M and Bekhet MM: Clinical
verification of a novel urinary microRNA panal: 133b, −342 and −30
as biomarkers for diabetic nephropathy identified by bioinformatics
analysis. Biomed Pharmacother. 83:92–99. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gnudi L, Coward RJ and Long DA: Diabetic
nephropathy: Perspective on novel molecular mechanisms. Trends
Endocrinol Metab. 27:820–830. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
John S: Complication in diabetic
nephropathy. Diabetes Metab Syndr. 10:247–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yun KJ, Kim HJ, Kim MK, Kwon HS, Baek KH,
Roh YJ and Song KH: Risk factors for the development and
progression of diabetic kidney disease in patients with type 2
diabetes mellitus and advanced diabetic retinopathy. Diabetes Metab
J. 40:473–481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kubota M, Watanabe R, Yamaguchi M,
Hosojima M, Saito A, Fujii M, Fujimura S and Kadowaki M: Rice
endosperm protein slows progression of fatty liver and diabetic
nephropathy in Zucker diabetic fatty rats. Br J Nutr.
116:1326–1335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Rasheed NM, Al-Rasheed NM, Al-Amin MA,
Hasan IH, Al-Ajmi HN, Mohammad RA and Attia HA: Fenofibrate
attenuates diabetic nephropathy in experimental diabetic rat's
model via suppression of augmented TGF-β1/Smad3 signaling pathway.
Arch Physiol Biochem. 122:186–194. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jose MJ, Varkey V, Chandni R, Zubaida PA
and Maliekkal J: The role of smoking as a modifiable risk factor in
diabetic nephropathy. J Assoc Physicians India. 64:34–38.
2016.PubMed/NCBI
|
|
11
|
Liljedahl L, Pedersen MH, Norlin J,
McGuire JN and James P: N-glycosylation proteome enrichment
analysis in kidney reveals differences between diabetic mouse
models. Clin Proteomics. 13:22–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang M, Yao D, Wang S, Yan Q and Lu W:
Long non-coding RNA ENSMUST00000147869 protects mesangial cells
from proliferation and fibrosis induced by diabetic nephropathy.
Endocrine. 54:81–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma R, Chaudhari S and Li W: Canonical
transient receptor potential 6 channel: A new target of reactive
oxygen species in renal physiology and pathology. Antioxid Redox
Signal. 25:732–748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hanefeld M, Appelt D, Engelmann K, Sandner
D, Bornstein SR, Ganz X, Henkel E, Haase R and Birkenfeld AL: Serum
and plasma levels of vascular endothelial growth factors in
relation to quality of glucose control, biomarkers of inflammation,
and diabetic nephropathy. Horm Metab Res. 48:6202016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ge J, Miao JJ, Sun XY and Yu JY: Huangkui
capsule, an extract from Abelmoschus manihot (L.) medic,
improves diabetic nephropathy via activating peroxisome
proliferator-activated receptor (PPAR)-α/γ and attenuating
endoplasmic reticulum stress in rats. J Ethnopharmacol.
189:238–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang YS, Lee MH, Song HK, Kim JE, Ghee JY,
Cha JJ, Lee JE, Kim HW, Han JY and Cha DR: Chronic administration
of visfatin ameliorated diabetic nephropathy in type 2 diabetic
mice. Kidney Blood Press Res. 41:311–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
You YK, Huang XR, Chen HY, Lyu XF, Liu HF
and Lan HY: C-reactive protein promotes diabetic kidney disease in
db/db Mice via the CD32b-Smad3-mTOR signaling Pathway. Sci Rep.
6:267402016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ji ZZ and Xu YC: Melatonin protects
podocytes from angiotensin II-induced injury in an in vitro
diabetic nephropathy model. Mol Med Rep. 14:920–926. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu Y, Tang L, Li Y and He Q: High
glucose-induced fibronectin upregulation in cultured mesangial
cells involves caveolin-1-dependent RhoA-GTP activation via Src
kinase. Mol Med Rep. 14:963–968. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Misra A and Shrivastava U: Obstructive
sleep apnea and diabetic nephropathy. Diabetes Technol Ther.
18:405–407. 2016. View Article : Google Scholar : PubMed/NCBI
|
